Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits

Retina

Volumn 28, Issue 2, 2008, Pages 350-355

  Ameri, Hossein ^a,d   Kim, June Gone ^a,b   Ratanapakorn, Tanapat ^a,c   Chader, Gerald J ^a   Humayun, Mark S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c KHON KAEN UNIVERSITY   (Thailand)

^d DOHENY EYE INSTITUTE   (United States)

Author keywords

Experimental retinal vein occlusion; Intravitreal injection of tPA; Rabbits; Subretinal injection of tPA

Indexed keywords

ALTEPLASE; ROSE BENGAL; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTOGRAPHY; RABBIT; RETINA VEIN OCCLUSION; REVASCULARIZATION; ANIMAL; DISEASE MODEL; INJECTION; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VITREOUS BODY;

ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; FLUORESCEIN ANGIOGRAPHY; INJECTIONS; RABBITS; RETINAL VEIN OCCLUSION; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VITREOUS BODY;

EID: 42449151371     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318140580c     Document Type: Article

References (17)

1. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.
2. Steinkamp GW, Hattenbach LO, Scharrer I, Ohrloff C. Front-loading rt PA thrombolytic therapy in central or venous branch occlusions of the retina. Ophthalmologe 1994;91:280-282.
3. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504.
4. Corbu C, Predoi D, Goicea D. Sulodexide treatment in retinal vein obstructions. Oftalmologia 1996;40:393-397.
5. Hattenbach LO, Steinkamp G, Scharrer I, Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998;212:394-398.
6. Hattenbach LO, Wellermann G, Steinkamp GW, et al. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica 1999;213:360-366.
7. Paques M, Vallee JN, Herbreteau D, et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 2000;84:1387-1391.
8. Vallee JN, Aymard A, Paques M, et al. Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion. J Radiol 2001;82:137-144.
9. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257.
10. Ghazi NG, Noureddine B, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 2003;23:780-784.
11. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-223.
12. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-613.
13. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-434.
14. Lam HD, Blumenkranz MS. Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation. Am J Ophthalmol 2002;134:609-611.
15. Oncel M, Peyman GA, Khoobehi B. Tissue plasminogen activator in the treatment of experimental retinal vein occlusion. Retina 1989;9:1-7.
16. Ma J, Ke Y, Wu D, et al. Experimental study on relationship between retinal vein occlusion and loss of vitreous gel mass. Mol Vis 2005;11:744-748.
17. Nanda SK, Hatchell DL, Tiedeman JS, et al. A new method for vascular occlusion. Photochemical initiation of thrombosis. Arch Ophthalmol 1987;105:1121-1214.